ATRS Antares Pharma Inc.

3.46
0  0%
Previous Close 3.46
Open 3.43
Price To Book 13.84
Market Cap 564,193,264
Shares 163,061,637
Volume 468,801
Short Ratio
Av. Daily Volume 788,227
Stock charts supplied by TradingView

NewsSee all news

  1. Antares Pharma to Present at the Ladenburg Thalmann 2019 Healthcare Conference

    EWING, N.J., Sept. 17, 2019 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced that Robert F. Apple, President and Chief Executive Officer, will present at the Ladenburg Thalmann 2019 Healthcare

Drug Information

Drug catalyst information is displayed when you hover over / tap on the stage bar graph.

Approved December 8, 2011.
Anturol
Overactive bladder
Approved Oct 14, 2013.
OTREXUP
Rheumatoid arthritis (RA)
Approval announced February 14, 2018.
Makena - auto injector
Reduce the risk of preterm birth in women with a singleton pregnancy
FDA Approval announced October 1, 2018.
XYOSTED (testosterone enanthate)
Testosterone deficiency

Latest News

  1. Antares Pharma to Present at the Ladenburg Thalmann 2019 Healthcare Conference

    EWING, N.J., Sept. 17, 2019 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced that Robert F. Apple, President and Chief Executive Officer, will present at the Ladenburg Thalmann 2019 Healthcare